Skip to main content
. 2022 Dec 30;15(1):186. doi: 10.3390/nu15010186

Table 3.

Concentrations of Hepcidin, Hemopexin, Ferritin, UIBC, and TIBC of athletes supplemented with colostrum bovine and with placebo.

Variables Before Supplementation p Value After Supplementation p Value
Pre-Exercise
x ± SD
Post-Exercise
x ± SD
Recovery
x ± SD
Pre
CON
vs.
SUPL
Post CON
vs.
SUPL
Recovery CON
vs.
SUPL
Pre-Exercise
x ± SD
Post-Exercise
x ± SD
Recovery
x ± SD
Pre CON vs. SUPL Post
CON vs. SUPL
Recovery
CON
vs.
SUPL
Hepcidin
(ng × dL−1)
PLACEBO 15.91 ± 1.29 14.81 ± 1.95 15.25 ± 2.70 0.213 0.890 0.979 19.10 ± 3.54 22.83 ± 2.60 a 22.50 ± 3.00 b 0.460 0.402 0.149
COLOSTRUM 14.91 ± 2.29 14.55 ± 1.82 14.89 ± 2.04 17.27 ± 3.83 21.19 ± 2.75 a 18.98 ± 3.33
Hemopexin
(µg × mL−1)
PLACEBO 614.64 ± 156.38 607.97 ± 138.93 672.14 ± 181.18 0.524 0.773 0.750 613.00 ± 108.27 685.78 ± 150.34 600.67 ± 179.83 0.722 0.551 0.894
COLOSTRUM 653.02 ± 144.18 614.61 ± 126.08 676.20 ± 150.73 616.33 ± 140.10 714.00 ± 152.41 a 655.85 ± 114.07 b
Ferritin
(ng × mL−1)
PLACEBO 88.55 ± 11.95 91.84 ± 15.84 86.43 ± 10.81 0.732 0.508 0.802 99.71 ± 43.50 90.84 ± 9.13 89.27 ± 6.96 0.638 0.431 0.313
COLOSTRUM 92.51 ± 10.47 90.08 ± 11.97 89.67 ± 10.74 93.84 ± 11.07 89.50 ± 8.50 86.92 ± 8.02
UIBC
(µg × dL−1)
PLACEBO 239.71 ± 86.10 259.76 ± 86.33 182.27 ± 49.26 b 0.777 0.934 0.525 255.52 ± 112.27 249.84 ± 71.29 200.45 ± 69.98 0.631 0.909 0.054
COLOSTRUM 224.33 ± 55.50 228.22 ± 93.67 245.15 ± 85.92 218.29 ± 58.55 245.97 ± 52.77 261.89 ± 55.26
TIBC
(µg × dL−1)
PLACEBO 325.59 ± 59.78 374.75 ± 66.40 a 297.77 ± 57.89 b 0.614 0.658 0.254 332.98 ± 83.48 367.55 ± 112.86 317.85 ± 83.98 0.995 0.582 0.327
COLOSTRUM 337.68 ± 50.22 360.19 ± 116.69 346.94 ± 83.82 322.51 ± 55.26 332.25 ± 65.02 353.76 ± 51.53

Note. Values are presented as mean ± SD; Significant differences p < 0.05; a Pre-exercise vs. Post-exercise; b Pre-exercise vs. Recovery. TIBC, total iron-binding capacity; UIBC, unsaturated iron-binding capacity. Bold values denote statistical significance at the p < 0.05 level.